Hyperlipidaemia advances and retreats.
出版信息
Br Med J. 1980 Aug 2;281(6236):340-1.
Abstract
摘要
相似文献
1
Hyperlipidaemia advances and retreats.
Br Med J. 1980 Aug 2;281(6236):340-1.
2
[Hyperlipidemia and coronary disease].
Coeur Med Interne. 1976 Jan-Mar;15(1):3-10.
3
Hyperlipidemia: reducing the chances of cardiovascular disease.
Geriatrics. 1984 Jul;39(7):99-100, 103-4,108-9 passim.
4
Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
Prog Biochem Pharmacol. 1974;9:82-98.
5
A pathophysiologic approach to managing hyperlipemia.
Am Fam Physician. 1976 Aug;14(2):78-87.
6
Treatment of essential hyperlipidaemia.
Lancet. 1970 Jan 24;1(7639):191-2. doi: 10.1016/s0140-6736(70)90430-7.
7
The investigation and treatment of hyperlipidaemia in general practice.
Practitioner. 1975 Mar;214(1281):393-6.
8
[Treatment of hyperlipidemia].
Nihon Naika Gakkai Zasshi. 1992 Nov 10;81(11):1750-5.
9
[Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Med Klin. 1973 Aug 24;68(34):1089-97.
10
Management of excess serum lipid.
N Engl J Med. 1971 May 13;284(19):1102-4. doi: 10.1056/nejm197105132841918.
本文引用的文献
1
Biliary lipid composition during treatment with different hypolipidaemic drugs.
Eur J Clin Invest. 1979 Jun;9(3):185-90. doi: 10.1111/j.1365-2362.1979.tb00921.x.
2
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.
Lancet. 1975 Jan 4;1(7897):16-9. doi: 10.1016/s0140-6736(75)92376-4.
Zotero 插件